EDUCATION:
2000 - SSK Okmeydanı Training and Research Hospital, .
1996 - Istanbul University, Istanbul Faculty of Medicine
EXPERIENCE:
2019 - Istanbul Medipol University Pendik Hospital
2017 - 2019 - Private Adatıp Kurtköy Hospital
2005 - 2017 - Private Avicenna Umut Hospital
2003 - 2005 - SSK Yalova Regional Hospital
2002 - 2003 - Kayseri Military Hospital
Medical Specialization YÜZÜNCÜ YIL UNIVERSITY
FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICINE/DEPARTMENT OF PEDIATRICS
2/Feb/2009
Name of Thesis: Screening for hematuria and proteinuria in school age children (2008) Supervisor:(ŞÜKRÜ ARSLAN)
Undergraduate Education SELÇUK UNIVERSITY
1997 MERAM FACULTY OF MEDICINE /MERAM MEDICAL PRACTICE.
30/June/ 2003
PROFESSOR ISTANBUL MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES
2019
/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)
ASSOCIATE PROFESSOR MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES
2014/-2019
/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)
ASSOCIATE PROFESSOR DÜZCE UNIVERSITY/FACULTY OF MEDICINE
2014/-2014
FACULTY MEMBER DUZCE UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL
2010/-2013
Supervised Theses
Medical Specialization
2022
MEDICAL SCIENCES/DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)
Cemalettin Güne , (2013). Investigation of Bone Metabolism Changes in Children with Type 1 Diabetes Mellitus,
DEPARTMENT OF CHILD HEALTH AND DISEASES/
Chief Physician ISTANBUL MEDIPOL UNIVERSITY/HEALTHCARE PRACTICE AND RESEARCH CENTER
2021
Birlikteli i: A case study Konuralp Tip Dergisi, 5(3), 58-61.
2009-2010 Specialist Doctor VAN GYNAECOLOGY AND PEDIATRIC HOSPITAL (State)
Parkinson's Disease Diagnosis and Treatments
Alzheimer's Diagnosis and Treatments
Epilepsy (Epileptic)
EEG and Treatment
Muscle and Nerve Disease Diagnosis and Treatments
Vertigo Diagnosis and Treatment
Restless Leg Syndrome
Stroke (Cerebral Palsy) Diagnosis and Treatment
Bartın State Hospital (2007-2009)
VM Medical Park Samsun Hospital (2009-2017)
VM Medical Park Samsun Hospital - Deputy Chief Physician (2019-2021)
Samsun Education and Research Hospital (2021-2022)
Çarşamba State Hospital
Private Atasam Samsun Hospital (2022-2024)
Karadeniz Technical University (1989-1995)
Ondokuz Mayis University Faculty of Medicine (2001-2006)
EXPERIENCE
1997 – today
Gayrettepe Florence Nightingale Hospital
Orthopedics and Traumatology specialist
1996 – 1997
Cerrahpaşa Faculty of Medicine Department of Orthopedics and Traumatology
Chief Assistant Specialist Doctor
1992 – 1996
Istanbul University Cerrahpaşa Faculty of Medicine
Orthopedics and Traumatology, Specialist
1992 – 1996
Cerrahpaşa Faculty of Medicine Department of Orthopedics and Traumatology
Assistant Physician
1987 – 1991
Adana Reşat Bey Health Center
General practitioner
1985 – 1987
Trabzon Maçka (Compulsory Service)
General practitioner
CLINICAL FOCUS
Sports Injuries
Orthopedic Trauma
Knee Arthroscopy
Hip Arthroscopy
EDUCATION
Istanbul University Cerrahpaşa Faculty of Medicine
Medical Education
Personal information
Title: Associate Professor
Branch: Anesthesiology
Work History:
1 Gayrettepe Florence Nightingale Hospital
Medical Specialties and Subspecialties:
1 Waist and Neck Pain
2 Cancer Pains
3 Spine Pains
4 Pain
Education
1991 - Istanbul University Cerrahpaşa Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Anesthesia and Reanimation
Specialization Training
2017 - Fellow of Interventional Pain Practice
2018- Certifield Interventional Pain Sonologist
International Articles
1 ÇÖMLEK SAVAŞ, MUTLU AYHAN, ÖZGÖNENEL EBRU, KAHRAMAN SİNAN, ÖZGÖNENEL LEVENT (2021). Atypical Fem-oral Fracture After Discontinuing Long-Term Bisphosphonate Use. Demiroğlu Bilim University Florence Nightingale
Medical Journal, 7(1), 52-56., Doi: 10.5606/fng.btd.2021.25048
2 POTTERY WAR, ORDU AYLIN (2021). Interventional Pain Management During SARS-CoV-2 Pandemic. Signa Vitae, 17(4),
178-184., doi: 10.22514/sv.2021.008
3 SAVAS COMLEK(2021). Transverse Abdominis Plane Block-Based Multimodal Analgesia Protocol Reduces Tramadol
Need After Cesarean Section. Bağcılar Medical Bulletin, 6(2), 134-141., Doi: 10.4274/BMB.galenos.2021.11.077
4 ÇÖMLEK SAVAS, SAĞLAM SEZER (2021). A New Approach for Leptomeningeal Metastases: Chemotherapy Adminis-
tered Through Lumbar Intrathecal Port. Arquivos de Neuro-Psiquiatria, Doi: 10.1590/0004-282X-ANP-2020-0554
5 SAVAS COMLEK(2021). Treatment Methods for Bone Metastasis-Induced Pain. Turkish Journal of Oncology, 36(1), 73-
78., Doi: 10.5505/tjo.2021.S1019
6 SAVAS COMLEK(2021). Ultrasound-Guided Interventions During Pregnancy for Lumbosacral Pain Unresponsive to Con-
servative Treatment: A Retrospective Review. Journal of Clinical Ultrasound, 49(1), 20-27., Doi: 10.1002/jcu.22923
7 SAVAS COMLEK(2020). Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac
Plexus Neurolysis. Journal of Pain Research, 13, 2023-2031., doi: 10.2147/JPR.S266689
8 SAVAS COMLEK(2020). Chemotherapy-Induced Pneumonitis Associated with Transient CA 15-3 Elevation. Journal of
Oncology Pharmacy Practice, 26(7), 1750-1753., Doi: 10.1177/1078155220904994
9 RAHİMİ MEHDİ, GÖĞÜZ DEMET, KAYA GÜNER, BOZKURT PERVİN, ÇÖMLEK SAVAŞ (2000). Patient Controlled Analgesia
(PCA) Application in Pediatric Patients. Ağrı, 12(1), 19-26.
10 BOZKURT PERVİN, KAYA GÜNER, TUNALI YUSUF, ÇÖMLEK SAVAŞ (1996). Bradyarrhythmia During Reperfusion in Kidney Transplantations (Case Report). Journal of the Turkish Society of Anesthesiology and Reanimation, 24(2), 92-94.
Istanbul University Istanbul Faculty of Medicine, Medicine, 02/07/2013
Istanbul University Istanbul Faculty of Medicine, Cardiovascular Surgery, 20/12/2018
Istanbul University Istanbul Faculty of Medicine: 2013-2019
Bağcılar Training and Research Hospital: 2019-2021
Istanbul Training Research Hospital: 2021-2023
Biruni University Hospital: 2023-Present
National Society of Vascular Surgery Congress-Oral Paper 2.2nd prize:
ÖZTAŞ DİDEM MELİS, Meriç Mert, BEYAZ METİN ONUR, Önalan Mehmet Akif, Bahşeliyev Şiraslan, SÖNMEZ KIVILCIM, ÖTER KEREM, ZİYADE SEDAT, ÖMER BEYHAN, ALPAGUT İBRAHİM UFUK, UĞURLUCAN MURAT (2019). Investigation of the Effect of Erythropoietin on Stem Cell Level in Cardiovascular Tissue in Diabetic Rats. 19th National Vascular and Endovascular Surgery Congress.
20 top ranked MRI of one area doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 MRI of one area doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous MRI of one area doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on MRI of one area varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for MRI of one area if you have any difficulties with a choice. Bookimed services are free for patients ♥
Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015
MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022
Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)
Medical Intrests
Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023
University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)
2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification
Undergraduate: Faculty of Medicine, Istanbul University Cerrahpaşa Faculty of Medicine, 2000-2006
MSc/Medical Specialization: Pediatrics, Şişli Etfal Training and Research Hospital, 2007-2012
PhD/Subspecialization in Medicine: Child Neurology, Medipol University, 2014-2017
Medical Specialization Research Assistant: Department of Physiology, Istanbul University Çapa Faculty of Medicine, 2006-2007
Specialist Doctor/State Service Obligation: Pediatrics, Sanliurfa Suruc State Hospital, 2012-2014
Subspecialty Specialist/Public Service Obligation: Pediatric Neurology, Istanbul Gaziosmanpaşa Training and Research Hospital, 2017-2020
Subspecialty Specialist Doctor/Dr. Faculty Member: Child Neurology, Istinye University Hospital, 2020-2024
Turkish Medical Association
Child Neurology Association of Turkey
Medical Intrests
Undergraduate Karadeniz Technical University 2001
PhD: Izmir Tepecik Training and Research Hospital Neurosurgery 2009
Konya Doğanhisar Başköy health center 2001-2002
Izmir Tepecik Training and Research Hospital 2004-2010
Agri State Hospital (Compulsory service) 2010-2011
Arnavutkoy State Hospital 2011-2012
Bakirkoy Sadi Konuk EAH 2012-2014
Istanbul Kanuni Training and Research Hospital 2015-2020
Başakşehir çam Sakura City Hospital 2020-2024
In 2009, I completed my specialty training in Neurosurgery and Neurosurgery at Izmir Tepecik Training and Research Hospital and worked as a specialist doctor at Istanbul Bakırköy Sadi Konuk EAH, Kanuni EAH and Başakşehir Çam and Sakura City Hospital affiliated to the University of Health Sciences. I have been working in the field of pediatric neurosurgery for 9 years. In 2024, I started to work as a Faculty Member at Biruni University Department of Neurosurgery and Neurosurgery.
Turkish Neurosurgical Society Membership
Pediatric Neurosurgery Group Membership
Turkish Medical Association
Doctor of Medicine: Istanbul University Cerrahpaşa Faculty of Medicine (1987-1993)
Neurology Specialist: Osmangazi University Faculty of Medicine (1997-2001)
Stroke Fellow: University of Calgary, Canada (2008-2009)
Assistant Professor: Trakya University Faculty of Medicine (2001-2006)
Associate Professor: Trakya University Faculty of Medicine (2006-2010), Bezmialem Faculty of Medicine (2010-2012)
Professor: Bezmialem Faculty of Medicine (2012-2017), Memorial Hizmet Hospital (2017-2019, 2021-2023)
Interventional Neurologist: King Hamad University Hospital, Bahrain (2019-2021)
Consultant Neurologist: Salmaniya Medical Complex, Bahrain (2023-2024)
Between 2008-2009, I worked as a stroke fellow at the University of Calgary Stroke Program for 1 year.
During my tenure at Bezmialem Vakıf University, I received interventional neurology training from Prof. Dr. Ömer Göktekin.
2019-2021 I worked as an interventional neurologist at Arabian Gulf University and King Hamad University Hospital in Bahrain.
I worked as a consultant neurologist at Salmaniya Medical Complex in Bahrain between 2023-2024.
Doctor: Kilis Merkez No. 1 Health Center, 2006-2008
Assistant Doctor: Mersin University Faculty of Medicine, 2009-2013
Specialist Doctor: Bingöl Genç State Hospital, 2013-2014
Minor Assistant: Akdeniz University Faculty of Medicine, 2014-2017
Minor Specialist: Erzurum Regional Training and Research Hospital, 2017-2018
Subspecialist: Gaziosmanpaşa Training and Research Hospital, 2018-2020
Attending Specialist: Başakşehir Çam and Sakura City Hospital, 2020-2022
Associate Professor: Başakşehir Çam and Sakura City Hospital, 2023
Associate Professor: Istinye University Medicalpark Gaziosmanpaşa Hospital, 2023-2024
Turkish Pediatric Society
Turkish Society for Pediatric Gastroenterology Hepatology and Nutrition
ESPGHAN - European Society for Pediatric Gastroenterology Hepatology and Nutrition.
My 34 years of medicine – which is more than half my life… After thousands of surgeries, the excitement and sense of responsibility of the first day still outweigh it. My father was a doctor, a neurologist too. I would always give the same response to those asking what I would be in elementary and secondary school: Neurosurgeon. When I started my neurosurgery residency at Haydarpaşa Numune Hospital in 1992, my childhood goal was fulfilled. Two points have always stood out from the others throughout my medical career: 1. Don’t harm anyone. 2. The most important relationship between the doctor and patient is the relationship of trust. In line with the principle of “first do no harm” in Turkish with “primum non nocere” in Latin, I have always preferred to perform secured surgeries under the microscope from smaller incisions. I didn’t perform any surgery that I wasn’t sure the patient would benefit from. So I’ve always been in a position to convince myself first of the need for surgery. Then I convince my patient. I kept in mind that the most important relationship between surgeon and patient is the relationship of trust. How can a person entrust his life to someone he saw 15 minutes ago without a relationship of trust? I cared about this relationship lasting post-surgery and even for life. I’ve had the first walks of my patients that I’ve operated in 28 years. Sometimes even after midnight many times… I’ve always cared about some patients’ feeling of their need to see their physician even at 03.00 o’clock midnight. I don’t mind giving all my patients my cell phone number. I would want my physician to be available at any time as needed. That’s what I do for my patients. In these lines, I felt the need to describe my view of medicine. Anyone who wonders anyway can reach my resume and my publications.
Prof. Dr. Halil Ibrahim Bekler was born in Istanbul in 1960. He completed his primary school education in Istanbul. He finished High School in Saint-Joseph in 1979. In 1985 he graduated from the Istanbul Faculty of Medicine. In the same year, he started to work as a resident doctor at Tokat Akbelen Health Center. Between 1987 and 1991, he specialized in Orthopedics and Traumatology at SiSli Etfal Hospital. Between 1993 and 1994, he worked as an assistant professor at Dicle University Faculty of Medicine in Diyarbakır, Turkey. Later, he worked as the Head of the Orthopedic and Traumatology Surgery Department at American Hospital. In 1999, he studied microsurgery at Cleveland Medical Center.
He worked as a specialist in Orthopedics and Traumatology Microsurgery in many private hospitals in Istanbul. Between 2006-2007, he worked as a Hand and Microsurgery Specialist at Columbia University School of Medicine. In 2008, he became an associate professor of orthopedics at Yeditepe University Faculty of Medicine. Between 2009 and 2015, he worked as Chief of Orthopedics at Lütfi Kırdar Kartal Hospital and he trained many Assistant Specialists. He became Professor in 2016.
He performs orthopedic microsurgery procedures at Avicenna Atasehir Hospital and offers effective treatments for knee and hip prostheses in the field of Orthopedics and Traumatology.
Experience
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
Liv Hospital
Liv Hospital Ulus
Acıbadem Bodrum Hospital
Tatvan State Hospital
Tatvan State Hospital
CLEVELAND CLINIC
Dokuz Eylul University Faculty of Medicine
Education
DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE, FACULTY OF MEDICINE/DEPARTMENT OF SURGICAL MEDICAL SCIENCES/DEPARTMENT OF GENERAL SURGERY
Dokuz Eylül University, General Surgery
AKDENİZ UNIVERSITY, FACULTY OF MEDICINE
Title: The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.
Title: Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.
Title: The effect of fibrin glue in preventing staple-line leak after sleeve gastrectomy: an experimental study in rats.
Title: Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
Title: Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid–low rectal cancer.
Title: Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?
Title: Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A single-center experience.
Title: Predictive factors for conversion to open surgery in laparoscopic colorectal surgery.
Experience
2019 – 2019
Insubria University Faculty of Medicine
2015
2013 – 2015
2010 – 2012
2002 – 2003
Education
2010
1992
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences